Kyverna Therapeutics Inc (KYTX) - News Archive

Breaking New Ground in Myasthenia Gravis Treatment: Positive Phase 2 Data from KYV-101 Study Marks a Milestone for Kyverna Therapeutics Compelling Results Set New Clinical Standard in Generalized Myasthenia Gravis (gMG)...

Promising Advances in Multiple Sclerosis Treatment: Kyverna Therapeutics Highlights KYV-101 at ECTRIMSKyverna Therapeutics is generating significant interest in the field of multiple sclerosis (MS) research with their r...

Advanced CAR T Therapy for Myasthenia Gravis: Kyverna Therapeutics Unveils Promising Developments Kyverna Therapeutics, a leader in cell therapy development, recently underscored the progress of its Neuroimmunology CAR...

In an urgent alert, the Rosen Law Firm, a highly recognized entity in the field of investor rights, has prompted investors of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) to secure legal counsel ahead of a critical Februar...

In a significant development for stakeholders of Kyverna Therapeutics, Inc. investors are being alerted to an impending class action lawsuit against the company. Levi & Korsinsky, LLP, a prominent securities litigation...

In a recent development significant to investors in the biotechnology sector, Rosen Law Firm, a prominent global investor rights law firm, has issued a reminder to those who purchased common stock of Kyverna Therapeutic...

Rosen Law Firm Urges Kyverna Therapeutics Investors to Take Legal Action by February Deadline In the turbulent world of biotechnology finance, investor confidence is a precious commodity. The case of Kyverna Therapeutic...

In the evolving landscape of biotech investments, the recent announcement from Rosen Law Firm regarding Kyverna Therapeutics, Inc. (NASDAQ: KYTX) has highlighted a significant potential legal battle stemming from the co...

Legal Advisory: Rosen Law Firm Urges Kyverna Therapeutics Investors to Secure Counsel Ahead of Important Deadline in Securities Class Action In the complex world of investments, particularly in the biotechnology sector,...